Page 51 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
BRCA VUS in breast cancer in MENA region

16. Bakkach J, Mansouri M, Derkaoui T, et al. Contribution doi: 10.1007/s11033-011-0829-8
of BRCA1 and BRCA2 germline mutations to early onset 26. Riahi A, Kharrat M, Ghourabi ME, et al. Mutation spectrum
breast cancer: A series from north of Morocco. BMC Cancer.
2020;20(1):859. and prevalence of BRCA1 and BRCA2 genes in patients with
familial and early-onset breast/ovarian cancer from Tunisia.
doi: 10.1186/s12885-020-07352-9 Clin Genet. 2015;87(2):155-160.
17. Mansouri M, Derkaoui T, Bakkach J, et al. Screening of doi: 10.1111/cge.12337
BRCA1 and BRCA2 germline mutations in unselected
triple‐negative breast cancer patients: A series from north of 27. Fourati A, Louchez MM, Fournier J, et al. Screening for
Morocco. Precis Med Sci. 2020;9(1):43-48. common mutations in BRCA1 and BRCA2 genes: Interest
in genetic testing of Tunisian families with breast and/or
doi: 10.1002/prm2.12009 ovarian cancer. Bull Cancer (Paris). 2014;101(11):E36-E40.
18. Laraqui A, Cavaillé M, Uhrhammer N, et al. Identification of doi: 10.1684/bdc.2014.2049
a novel pathogenic variant in PALB2 and BARD1 genes by a
multigene sequencing panel in triple negative breast cancer 28. Msolly A, Kassab A. BRCA1 and BRCA2 mutations are they
in Morocco. J Genomics. 2021;9:43-54. related to breast cancer in a sample of Tunisian population?
Cancer Ther Oncol Int J. 2015;1(1):1-5.
doi: 10.7150/jgen.61713
doi: 10.19080/ctoij.2015.01.555551
19. Laraqui A, Uhrhammer N, Lahlou-Amine I, et al. Mutation
screening of the BRCA1 gene in early onset and familial 29. Ben Ayed-Guerfali D, Ben Kridis-Rejab W, Ammous-
breast/ovarian cancer in Moroccan population. Int J Med Boukhris N, et al. Novel and recurrent BRCA1/BRCA2
Sci. 2012;10(1):60-67. germline mutations in patients with breast/ovarian
cancer: A series from the south of Tunisia. J Transl Med.
doi: 10.7150/ijms.5014 2021;19(1):1-10.
20. Cherbal F, Bakour R, Adane S, Boualga K. BRCA1 and doi: 10.1186/s12967-021-02772-y
BRCA2 germline mutation spectrum in hereditary breast/
ovarian cancer families from Maghrebian countries. Breast 30. Hamdi Y, Mighri N, Boujemaa M, et al. Identification of
Dis. 2012;34(1):1-8. eleven novel BRCA mutations in Tunisia: Impact on the
clinical management of BRCA related cancers. Front Oncol.
doi: 10.3233/BD-130348 2021;11:674965.
21. Uhrhammer N, Abdelouahab A, Lafarge L, Feille V, doi: 10.3389/fonc.2021.674965
Dib AB, Bignon YJ. BRCA1 mutations in Algerian breast
cancer patients: High frequency in young, sporadic cases. 31. AbdelHamid S, El-Mesallamy H, Aziz HA, Zekri AR.
Int J Med Sci. 2008;5(4):197-202. Prognostic impact of BRCA1 and BRCA2 mutations on
long-term survival outcomes in Egyptian female breast
doi: 10.7150/ijms.5.197 cancer patients. Biology. 2021;10(7):566.
22. Henouda S, Bensalem A, Reggad R, Serrar N, Rouabah L, doi: 10.3390/biology10070566
Pujol P. Contribution of BRCA1 and BRCA2 germline
mutations to early algerian breast cancer. Dis Markers. 32. Abdel-Razeq H, Al-Omari A, Zahran F, Arun B. Germline
2016;2016:7869095. BRCA1/BRCA2 mutations among high risk breast cancer
patients in Jordan. BMC Cancer. 2018;18(1):152.
doi: 10.1155/2016/7869095
doi: 10.1186/s12885-018-4079-1
23. Troudi W, Uhrhammer N, Sibille C, et al. Contribution
of the BRCA1 and BRCA2 mutations to breast cancer in 33. Abdel-Razeq H, Abujamous L, Abunasser M, Edaily S,
Tunisia. J Hum Genet. 2007;52(11):915-920. Bater R. Prevalence and predictors of germline BRCA1 and
BRCA2 mutations among young patients with breast cancer
doi: 10.1007/s10038-007-0195-5
in Jordan. Sci Rep. 2021;11:14906.
24. Troudi W, Uhrhammer N, Ben RK, et al. Complete mutation doi: 10.1038/s41598-021-94403-1
screening and haplotype characterization of BRCA1 gene
in Tunisian patients with familial breast cancer. Cancer 34. Merdad A, Gari MA, Hussein S, et al. Characterization
Biomark. 2008;4(1):11-18. of familial breast cancer in Saudi Arabia. BMC Genomics.
2015;16(Suppl 1):S3.
doi: 10.3233/CBM-2008-4102
doi: 10.1186/1471-2164-16-S1-S3
25. Mahfoudh W, Bouaouina N, Ahmed SB, et al. Hereditary
breast cancer in Middle Eastern and North African (MENA) 35. Alhuqail A, Alzahrani A, Almubarak H, et al. High
populations: Identification of novel, recurrent and founder prevalence of deleterious BRCA1 and BRCA2 germline
BRCA1 mutations in the Tunisian population. Mol Biol mutations in arab breast and ovarian cancer patients. Breast
Rep. 2012;39(2):1037-1046. Cancer Res Treat. 2018;168(3):695-702.

Volume 9 Issue 1 (2025) 43 doi: 10.36922/ejmo.5800